Skip to main navigation Skip to search Skip to main content

Smoking and autoimmune thyroid disease: the plot thickens

  • Gerasimos E. Krassas
  • , Wilmar Wiersinga

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

New studies have shown that smoking may protect against the development of thyroid peroxidase antibodies, which may result in a decreased risk of Hashimoto's hypothyroidism (HH), whereas it stimulates the development of Graves' hyperthyroidism (GH). According to the above-mentioned hypothesis, to stop smoking would decrease the risk of GH but increase the risk of HH. Also, smoking has been identified as one of the risk factors for the development or worsening of eye changes after 131I treatment of GH. Additionally, the outcome of medical treatment of Graves' ophthalmopathy (GO) is less favourable in smokers as compared to non-smokers. There is concern also about the effect of passive smoking on autoimmune thyroid disease. In a recent study it has been shown that the latter may have a deleterious effect on childhood GO
Original languageEnglish
Pages (from-to)777-780
JournalEuropean journal of endocrinology / European Federation of Endocrine Societies
Volume154
Issue number6
DOIs
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'Smoking and autoimmune thyroid disease: the plot thickens'. Together they form a unique fingerprint.

Cite this